NitroMed, Johnson & Johnson Co. deal

The companies will develop NitroMed's nitric-oxide-donor nonsteroidal anti-inflammatory drugs (NO-NSAIDs). J&J's

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE